Respiratory COPD Exacerbation

BAP-65 and DECAF Score

Downloads
Revenue

Description

"Respiratory COPD Exacerbation - BAP-65 and DECAF Score" is a mobile app designed to help with health practitioner in assessing the severity and predicting the outcome in acute exacerbation of chronic obstructive pulmonary disease (COPD) by using BAP-65 and DECAF Score. Chronic obstructive pulmonary disease (COPD) is defined as a common preventable and treatable disease, characterised by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients.
There are several features of "Respiratory COPD Exacerbation - BAP-65 and DECAF Score", namely:
- Simple and very easy to use COPD app.
- Precise calculation and classification with BAP-65 score.
- Easy calculation and interpretation of DECAF score.
- Assess severity and predict outcome of acute COPD exacerbation.
- It is totally free. Download now!
Both BAP-65 and DECAF score in "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app correlates well with both in-hospital mortality and need for mechanical ventilation in patients with COPD. The BAP-65 system is a score composed of 4 variables. All of them are available upon presentation to the hospital. The B letter stands for Blood Urea Nitrogen (BUN) and it is positive if level is above 25 mg/dL. The A letter stands for Altered Mental Status and it is counted positive when the initial Glasgow Coma Scale (GCS) is 14 or less, or when the physician has designated that the patient was disoriented, stuporous or in coma. The P letter stands for Pulse and it is positive when the initial pulse is above 109 beats/min. Finally, an additional point will be added if the patient was above 65 years old.
While DECAF score is a simple, reliable, accurate prediction tool could potentially improve patient care, by identifying patients suitable for hospital discharge or for more intensive therapy / monitoring. DECAF is simple to calculate and apply at the bedside. It requires an assessment of the patient’s usual level of breathlessness and function: the eMRCD score.

Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "Respiratory COPD Exacerbation - BAP-65 and DECAF Score" app might be different with your local practice. Consult to expert doctor whenever necessary.
Hide Show More...

Screenshots

Respiratory COPD Exacerbation FAQ

  • Is Respiratory COPD Exacerbation free?

    Yes, Respiratory COPD Exacerbation is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Respiratory COPD Exacerbation legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Respiratory COPD Exacerbation cost?

    Respiratory COPD Exacerbation is free.

  • What is Respiratory COPD Exacerbation revenue?

    To get estimated revenue of Respiratory COPD Exacerbation app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Nigeria yet.
Ratings History

Respiratory COPD Exacerbation Reviews

No Reviews in Nigeria
App doesn't have any reviews in Nigeria yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Respiratory COPD Exacerbation Competitors

Name
COPD Manager
Chronic Pulmonary Obstruction
Pulmonology and Allergy
Clinical Decision Support Tool
N/A
COPD @Point of Care™
PFT eval
guidance on spirometry & PFT's
ATS Journals App
EBMcalc Pulmonary
Ventilator Guide
Learn about your ventilator
Mosby's PDQ Respiratory Care
Pulmonary Reference
Quick Reference-Critical Care

Respiratory COPD Exacerbation Installs

Last 30 days

Respiratory COPD Exacerbation Revenue

Last 30 days

Respiratory COPD Exacerbation Revenue and Downloads

Gain valuable insights into Respiratory COPD Exacerbation performance with our analytics.
Sign up now to access downloads, revenue, and more.